Tykerb for Breast Cancer
A prescription medication, Tykerb® (lapatinib) is approved for the treatment of breast cancer, specifically for cases that have spread to other parts of the body and have not responded to other treatments. Tykerb is used in combination with Xeloda® (capecitabine), a chemotherapy medication. Unlike many cancer medications, both Tykerb and Xeloda are taken by mouth, not by IV (intravenously).
Tykerb comes in tablet form and is usually taken once a day. Common side effects include vomiting, rash, and diarrhea.
(For more details on this breast cancer medication, including how it works to slow the growth of cancer cells, click Tykerb Uses.)